Human medicines European public assessment report (EPAR): Celvapan, influenza vaccine (H1N1)v (wholThe marketing authorisation for Celvapan has been withdrawn at the request of the marketing-authorisation holder. READ MORE #Pharmanews
The marketing authorisation for Celvapan has been withdrawn at the request of the marketing-authorisation holder. READ MORE #Pharmanews
Guideline on good pharmacovigilance practices (GVP) - Module VI – Collection, management and submiss
